The Challenges Ahead With Monoclonal Antibodies- From Authorization to Access

11 Novembre 2020

When President Trump received an infusion of a monoclonal antibody cocktail (REGN-COV2 from Regeneron) on October 2, 2020, his physicians were presumably reacting to promising data reported in the company’s news release from 3 days earlier.

Prosegui la lettura

Avviso sui cookie di WordPress da parte di Real Cookie Banner